Latest

neuropharmacology

This shows researchers standing around a computer monitor.

·September 25, 2024·7 min read

AI Revolutionizes Drug Discovery for Rare Diseases

AI tool has identified drug candidates for over 17,000 rare and untreated diseases, offering hope for millions of affected individuals. This tool, TxGNN, stands out as the first model developed specifically to repurpose existing drugs for neglected conditions. It predicts which drugs may work and potential side effects, providing new avenues for treatment. The AI model is free to use and aims to expedite therapeutic discoveries for patients in need.

Featured Neurology Neuroscience

·September 24, 2024·5 min read

Parkinson’s Drug Linked to Impaired Decision-Making

Pramipexole, a Parkinson’s disease (PD) drug, impairs decision-making by hyperactivating the brain’s external globus pallidus (GPe) region. This research uncovers how the medication, while effective for PD symptoms, can lead to risky behaviors like gambling.

Featured Neuroscience Pain

·September 24, 2024·3 min read

Dopamine Not Essential for Placebo Effect in Pain Relief

New research reveals that dopamine is not directly responsible for the formation of placebo analgesia, contrary to previous beliefs. In a study with 168 participants, altering dopamine levels did not affect positive treatment expectations or pain relief.

Brain Cancer Featured Neurology Neuroscience

·September 22, 2024·5 min read

Antidepressant May Help Fight Glioblastoma Brain Tumors

Researchers have discovered that the antidepressant vortioxetine effectively combats glioblastoma, a deadly brain tumor, in lab tests and in mice. This drug, already FDA-approved, crosses the blood-brain barrier and could potentially improve treatment for glioblastoma patients when combined with standard therapy.

Featured Neuroscience

·September 9, 2024·3 min read

How Propofol Disrupts Consciousness Pathways

Researchers have mapped how propofol, a widely used anesthetic, alters brain connectivity to induce unconsciousness. Using fMRI, they found that propofol disrupts connections in the thalamus, reducing complex information processing and limiting sensory integration.

Featured Neuroscience Psychology

·September 4, 2024·5 min read

No Link Found Between Ozempic and Suicide Risk

A new study has found no evidence that GLP-1 analogues, common diabetes drugs, increase the risk of suicide, self-harm, or related mental health issues. Researchers analyzed data from around 300,000 people treated with these medications and found no clear link between the drugs and mental health risks.

Featured Neurology Neuroscience

·September 4, 2024·4 min read

Drug Trial Offers Hope for Progressive Supranuclear Palsy

A new clinical trial will test three drugs concurrently to find treatments for progressive supranuclear palsy (PSP), a rare and fatal neurodegenerative disorder. The trial aims to slow the relentless progression of PSP, which currently has no cure.

Featured Neurology Neuroscience

·September 4, 2024·5 min read

Novel Drug Shows Promise in Preventing Early Alzheimer’s Brain Changes

A recent study has shown that troriluzole can prevent early-stage brain changes in a mouse model of Alzheimer’s disease. The research demonstrated that troriluzole reduces harmful glutamate levels, preserving memory and cognitive function.

Featured Neurology Neuroscience Pain

·August 30, 2024·3 min read

Morphine’s Pain Relief Mechanism Unveiled

Researchers have uncovered how morphine relieves pain by activating a specific group of neurons in the brain, termed the 'morphine ensemble.' These neurons, located in the rostral ventromedial medulla (RVM), connect to the spinal cord and inhibit pain signaling. Understanding this pathway could help reduce the severe side effects of morphine, such as addiction and overdose. The findings also provide insights into the differences between pain relief and the euphoric effects of morphine.

Featured Neurology Neuroscience

·August 6, 2024·5 min read

Dopamine Treatment Reduces Alzheimer’s Plaques

Researchers uncovered a promising approach to treating Alzheimer’s disease by using dopamine to enhance brain enzyme activity that reduces harmful plaques. Conducted on mice, the study shows that dopamine increases neprilysin production, which breaks down beta-amyloid plaques linked to Alzheimer's.

This shows a brain surrounded by seaweed.

Featured Neurology Neuroscience

·August 5, 2024·3 min read

Seaweed Antioxidants Show Promise in Preventing Parkinson’s

Researchers have found that antioxidants from Ecklonia cava, a type of seaweed, may help prevent Parkinson's disease by protecting dopamine-producing neurons. In mouse models, these antioxidants restored motor function and improved gut health after exposure to toxins. Cellular studies revealed that these compounds activate the AMPK enzyme and reduce harmful reactive oxygen species, potentially offering a new approach to combat neurodegeneration. This discovery highlights the potential of Ecklonia cava as a preventive ingredient against Parkinson's disease.

Featured Genetics Neurology Neuroscience

·August 5, 2024·5 min read

Genetically Engineered Parasite Delivers Drugs to the Brain

Researchers genetically engineered the parasite Toxoplasma gondii to deliver drugs across the blood-brain barrier. This innovative approach has been used to deliver therapeutic proteins to neurons, showing promise for treating neurological conditions like Rett syndrome. The research highlights the potential for parasites to act as delivery vehicles for large molecules that typically struggle to penetrate the brain. This breakthrough could lead to new treatments for a variety of neurological disorders.

1 … 13 14 15 16 17 … 85

neuropharmacology

AI Revolutionizes Drug Discovery for Rare Diseases

Parkinson’s Drug Linked to Impaired Decision-Making

Dopamine Not Essential for Placebo Effect in Pain Relief

Antidepressant May Help Fight Glioblastoma Brain Tumors

How Propofol Disrupts Consciousness Pathways

No Link Found Between Ozempic and Suicide Risk

Drug Trial Offers Hope for Progressive Supranuclear Palsy

Novel Drug Shows Promise in Preventing Early Alzheimer’s Brain Changes

Morphine’s Pain Relief Mechanism Unveiled

Dopamine Treatment Reduces Alzheimer’s Plaques

Seaweed Antioxidants Show Promise in Preventing Parkinson’s

Genetically Engineered Parasite Delivers Drugs to the Brain

Glioblastoma’s Chaos Follows Predictable Rules

One Autism Mutation Collapses the Whole Gene Network

Why Bitter Coffee Starts to Taste So Good to Your Brain

Omega-3 DHA Eases Autism Behaviors by Calming Inflammation

Subscribe